Open up the NHS to our drug firms, White House demands (1)

Imagine a world where the drugs companies have unrestricted access to the NHS for any and all drugs they chose to sell without the need to go through the proper regulatory channels? This is the world that the USA is trying to force on the UK via intense lobbing of British ministers.

Open up NHS to our drug firms, White House demands

Sarah Boseley, health editor
Tuesday November 14, 2006
The Guardian

The White House is lobbying British ministers to allow the world’s main drug companies unrestricted access to the NHS as part of a package of free market reforms for the service. The US government is positioning itself behind the giant pharmaceutical firms, predominantly based in America, which have been piling pressure on the body that approves drugs for use in hospitals and for prescription by GPs.

The drug companies claim that they are being held back by the National Institute for Clinical Excellence and have separately lobbied for it to be reformed.

In a surprising intervention, the US deputy health secretary, Alex Azar, forced the issue in London yesterday, ahead of talks with officials following a trip to the US last week by the health secretary, Patricia Hewitt. He said attempts to use rationing mechanisms such as Nice to cut soaring drugs bills would stifle innovation – an argument that is constantly made by the pharmaceutical industry.

Click here for the full story….

Add a Comment Cancel reply

Share:

Our weekly roundup of the latest natural news from across the globe in one place. This week: Are digital spaces harmful to young people?; Food preservatives & T2D; Gut health & brain health; Changes to US & UK childhood vax schedules; Being creative keeps our brains young; Updates from ANH-USA; Threats to Free Speech; Post-covid related and much more…